Central nervous system sites of the sleep promoting effects of eszopiclone in rats

Neuroscience

Volumn 181, Issue , 2011, Pages 67-78

  Kumar, S ^a   Alam, M N ^a,b   Rai, S ^a   Bashir, T ^a   McGinty, D ^a,b   Szymusiak, R ^a,c  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

GABA A receptors; Hypnotic medication; Hypocretin; Orexin; Preoptic hypothalamus

Indexed keywords

ESZOPICLONE; NEUROTRANSMITTER; OREXIN; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL TYPE; CENTRAL NERVOUS SYSTEM; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; DARKNESS; DORSAL RAPHE; DRUG DOSE COMPARISON; DRUG EFFECT; FOREBRAIN; GABAERGIC SYSTEM; HYPOTHALAMUS; LATERAL HYPOTHALAMUS; LOW DRUG DOSE; MALE; MICRODIALYSIS; NONHUMAN; NONREM SLEEP; PREOPTIC AREA; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL; SLEEP INDUCTION; SLEEP TIME; SLEEP WAKING CYCLE; WAKEFULNESS;

ANIMALS; AZABICYCLO COMPOUNDS; BRAIN; HISTORY, ANCIENT; HYPNOTICS AND SEDATIVES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NEUROPEPTIDES; PIPERAZINES; RATS; RATS, SPRAGUE-DAWLEY; SLEEP;

EID: 79953675340     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.03.006     Document Type: Article

References (53)

1. Adamantidis A., Zhang F., Aravanis A., Deisseroth K., de Lecea L. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature 2007, 450:420-424.
2. Alam M.N., Kumar S., Bashir T., Suntsova N., Methippara M.M., Szymusiak R., McGinty D. GABA-mediated control of hypocretin- but not melanin-concentrating homone-immunoreactive neurons during sleep in rats. J Physiol 2005, 563:569-582.
3. Alam M.N., Kumar S., Rai S., Methippara M.M., Szymusiak R., McGinty D. Role of adenosine A(1) receptor in the perifornical lateral hypothalamic area in sleep-wake regulation in rats. Brain Res 2009, 1304:96-104.
4. Alam M.N., Kumar S., Suntsova N., Bashir T., Szymusiak R., McGinty D. GABAergic regulation of perifornical lateral hypothalamus neurons during nonrapid eye movement sleep in rats. Neuroscience 2010, 167:920-928.
5. Backberg M., Ultenius C., Fritschy J., Meister B. Cellular localization of GABA receptor alpha subunit immunoreactivity in rat hypothalamus: relationship with neurons containing orexigenic or anorexigenic peptides. J Neuroendocrinol 2004, 16:589-604.
6. Baker F.C., Shah S., Stewart D., Angara C., Gong H., Szymusiak R., Opp M.R., McGinty D. Interleukin 1β enhances non-rapid eye movement sleep and increases c-Fos protein expression in the median preoptic nucleus of the hypothalamus. Am J Physiol Regul Integr Comp Physiol 2005, 288:R998-R1005.
7. Bonnet M., Arand D. Hyperarousal and insomnia: state of the science. Sleep Med Rev 2010, 14:9-15.
8. Brielmaier B.D. Eszopiclone (Lunesta): a new nonbenzodiazepine hypnotic agent. Proc (Bayl Univ Med Cent) 2006, 19:54-59.
9. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999, 98:437-451.
10. Chen H., Kuo T., Shaw F., Lai C., Yang C. Sleep-related vagontonic effect of zolpidem in rats. Psychopharmacology (Berl) 2005, 181:270-279.
11. Davies M., Newell J., Derry J., Martin I., Dunn S. Characterization of the interaction of zopiclone with gamma aminobutyric acid type A receptors. Mol Pharamacol 2000, 58:756-762.
12. Espana R.A., Scammell T.E. Sleep neurobiology for the clinician. Sleep 2004, 27:811-820.
13. Estabrooke I.V., McCarthy M.T., Ko E., Chou T.C., Chemelli R.M., Yanagisawa M., Saper C.B., Scammell T.E. Fos expression in orexin neurons varies with behavioral state. J Neurosci 2001, 21:1656-1662.
14. Gauthier P., Arnaud C., Stutzman J., Gottesman C. Influence of zopiclone, a new generation hypnotic, on the intermediate stage and paradoxical sleep in the rat. Psychopharmacology (Berl) 1997, 130:139-143.
15. Gerashchenko D., Kohls M., Greco M.A., Waleh N., Salin-Pascual R., Kilduff T.S., Lappi D., Shiromani P. Hypocretin-2 saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in rats. J Neurosci 2001, 21:7273-7283.
16. Gong H., McGinty D., Guzman-Marin R., Chew K.T., Stewart D., Szymusiak R. Activation of c-Fos in GABAergic neurones in the preoptic area during sleep and in response to sleep deprivation. J Physiol 2004, 556:935-946.
17. Gong H., Szymusiak R., King J., Steininger T., McGinty D. Sleep-related c-Fos protein expression in the preoptic hypothalamus: effects of ambient warming. Am J Physiol 2000, 279:R2079-R2088.
18. Gvilia I., Xu F., McGinty D., Szymusiak R. Homeostatic regulation of sleep: a role for preoptic area neurons. J Neurosci 2006, 26:9426-9433.
19. Harrison N. Mechanisms of sleep induction by GABA-A receptor agonsists. J Clin Psychiatry 2007, 68(Suppl 5):6-12.
20. Huang M., Radadia K., Macone B., Auerbach S., Datta S. Effects of eszopiclone and zolpidem on sleep-wake behavior, anxiety-like behavior and contextual memory in rats. Behav Brain Res 2010, 210:54-66.
21. A receptors in the thalamus by eszopiclone and zolpidem. J Pharmacol Exp Ther 2009, 328:1000-1006.
22. Kumar S., Szymusiak R., Bashir T., Rai S., McGinty D., Alam M.N. Effects of serotonin on perifornical lateral hypothalamic area neurons in rat. Eur J Neurosci 2007, 25:201-212.
23. Lin J.S., Sakai K., Vanni-Mercier G., Jouvet M. A critical role of the posterior hypothalamus in the mechanisms of wakefulness determined by microinjection of muscimol in freely moving cats. Brain Res 1989, 479:225-240.
24. Lu J., Nelson L., Franks N., Maze M., Chamberlin N.L., Saper C.B. Role of endogenous sleep-wake and analgesic systems in anesthesia. J Comp Neurol 2008, 508:648-662.
25. McCall W., Erman M., Krystal A., Rosenberg R., Scharf M., Zammit G., Wessel T. A polysomnographic study of eszopiclone in elderly patients with insomnia. Curr Med Res Opin 2006, 9:1633-1642.
26. Methippara M.M., Bashir T., Suntsova N., Szymusiak R., McGinty D. Hippocampal adult neurogenesis is enhanced by chronic eszopiclone treatment in rats. J Sleep Res 2010, 19:384-393.
27. Mochizuki T., Crocker A., McCormack S., Yanagisawa M., Sakurai T., Scammel T. Behavioral state instability in orexin knock-out mice. J Neurosci 2004, 24:6291-6300.
28. Morairty S., Hedley L., Flores J., Martin R., Kilduff T.S. Selective 5HT2A and 5HT6 receptor antagonists promote sleep in rats. Sleep 2008, 31:34-44.
29. Nelson L.E., Guo T.Z., Lu J., Saper C.B., Franks N.P., Maze M. The sedative component of anesthesia is mediated by GABA(A) receptors in an endogenous sleep pathway. Nat Neurosci 2002, 5:979-984.
30. Nofzinger E., Buysse D., Germain A., Price J., Miewald J., Kupfer D. Functional neuroimaging evidence for hyperarousal in insomnia. Am J Psychiatry 2004, 161:2126-2128.
31. Noguchi H., Kitazumi K., Mori M., Shiba T. Electroencephalographic properties of zaleplon, a nonbenzodiazepine sedative/hypnotic, in rats. J Pharmacol Sci 2004, 94:246-251.
32. Ohno K., Sakurai T. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness. Front Neuroendocrinol 2008, 29:70-87.
33. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1998, Academic Press, San Diego.
34. Perlis M., Smith M., Andrews P., Orff H., Giles D. Beta/gamma EEG activity in patients with primary and secondary insomnia and good sleeper controls. Sleep 2001, 24:110-117.
35. Perlis M.L., Giles D., Mendelson W.B., Bootzin R., Wyatt J. Psychophysiological insomnia: the behavioral model and a neurcognitive perspective. J Sleep Res 1997, 6:179-188.
36. Peterfi Z., McGinty D., Sarai E., Szymusiak R. Growth hormone-releasing hormone activates sleep regulatory neurons of the rat preoptic hypothalamus. Am J Physiol 2010, 298:R147-R156.
37. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998, 18:9996-10015.
38. Riemann D., Spiegelhalder K., Feige B., Voderholzer U., Berger M., Perlis M., Nissen C. The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev 2010, 14:19-31.
39. Roth T. A physiologic basis for the evolution of pharmacotherapy for insomnia. J Clin Psychiatry 2007, 68(Suppl 5):13-18.
40. Roth T., Walsh J., Krystal A., Wessel T., Roehrs T. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. Sleep Med 2005, 6:487-495.
41. Saper C.B. Staying awake for dinner: hypothalamic integration of sleep, feeding and circadian rhythms. Prog Brain Res 2006, 153:243-252.
42. Scharf M., Erman M., Rosenberg R., Seiden D., Mcall W., Amato D., Wessel T. A 2-week efficacy and safety study of eszpiclone in elderly patients with primary insomnia. Sleep 2005, 28:720-727.
43. Sherin J.E., Shiromani P.J., McCarley R.W., Saper C.B. Activation of ventrolateral preoptic neurons during sleep. Science 1996, 271:216-219.
44. Shinomiya K., Shigemoto Y., Okuma C., Mio C., Kamei C. Effects of short-acting hypnotics on sleep latency in rats placed on grid suspended over water. Eur J Pharmacol 2003, 460:139-144.
45. Sigel B., Buhr A. The benzodiazepine binding site of GABA-A receptors. Trends Pharmacol Sci 1997, 18:425-429.
46. Smith G., Olsen R. Functional domains of GABA-A receptors. Trends Pharmacol Sci 1995, 16:162-168.
47. Soares C., Joffe H., Rubens R., Caron J., Roth T., Cohen L. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized control trial. Obstet Gynecol 2006, 108:1402-1410.
48. Suntsova N., Szymusiak R., Alam M.N., Guzman-Marin R., McGinty D. Sleep-waking discharge patterns of median preoptic nucleus neurons. J Physiol 2002, 543:665-677.
49. Szymusiak R., Alam N., Steininger T.L., McGinty D. Sleep-waking discharge patterns of ventrolateral preoptic/anterior hypothalamic neurons in rats. Brain Res 1998, 803:178-188.
50. Thakkar M.M., Engemann S.C., Walsh K.M., Sahota P.K. Adenosine and the homeostatic control of sleep: effects of A1 receptor blockade in the perifornical lateral hypothalamus on sleep-wakefulness. Neuroscience 2008, 153:875-880.
51. Walsh J., Krystal A., Amato D., Rubens R., Caron J., Wessel T., Schaefer K., Roach J., Wallenstein G., Roth T. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep 2007, 30:959-968.
52. A receptors in the physiology and pharmacology of sleep. Eur J Neurosci 2009, 29:1779-1794.
53. Xi M., Chase M.H. Effects of eszopiclone and zolpidem on sleep and waking states in the adult guinea pig. Sleep 2008, 31:1043-1051.